| 1 |
Ardini M, Vago R, Fabbrini MS, Ippoliti R. From Immunotoxins to Suicide Toxin Delivery Approaches: Is There a Clinical Opportunity? Toxins (Basel) 2022;14:579. [PMID: 36136517 DOI: 10.3390/toxins14090579] [Reference Citation Analysis]
|
| 2 |
Wang L, Fang D, Xu J, Luo R. Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review. BMC Cancer 2020;20:1059. [PMID: 33143662 DOI: 10.1186/s12885-020-07568-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 3 |
Singh AK, Verma A, Singh A, Arya RK, Maheshwari S, Chaturvedi P, Nengroo MA, Saini KK, Vishwakarma AL, Singh K, Sarkar J, Datta D. Salinomycin inhibits epigenetic modulator EZH2 to enhance death receptors in colon cancer stem cells. Epigenetics 2021;16:144-61. [PMID: 32635858 DOI: 10.1080/15592294.2020.1789270] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 4 |
Singh AK, Verma A, Singh A, Arya RK, Maheshwari S, Chaturvedi P, Nengroo MA, Saini KK, Vishwakarma AL, Singh K, Sarkar J, Datta D. Salinomycin inhibits epigenetic modulator EZH2 to enhance Death Receptors in Colon Cancer Stem Cells.. [DOI: 10.1101/2020.02.03.932269] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 5 |
Li K, Fang D, Xiong Z, Luo R. Inhibition of the hedgehog pathway for the treatment of cancer using Itraconazole. Onco Targets Ther 2019;12:6875-86. [PMID: 31692536 DOI: 10.2147/OTT.S223119] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 6 |
Fu B, Xi S, Wang Y, Zhai X, Wang Y, Gong Y, Xu Y, Yang J, Qiu Y, Wang J, Lu D, Huang S. The Protective Effects of Ciji-Hua'ai-Baosheng II Formula on Chemotherapy-Treated H22 Hepatocellular Carcinoma Mouse Model by Promoting Tumor Apoptosis. Front Pharmacol 2018;9:1539. [PMID: 30670974 DOI: 10.3389/fphar.2018.01539] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Moradi Marjaneh R, Hassanian SM, Ghobadi N, Ferns GA, Karimi A, Jazayeri MH, Nasiri M, Avan A, Khazaei M. Targeting the death receptor signaling pathway as a potential therapeutic target in the treatment of colorectal cancer. J Cell Physiol 2018;233:6538-49. [DOI: 10.1002/jcp.26640] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 8 |
Ko JH, Sethi G, Um JY, Shanmugam MK, Arfuso F, Kumar AP, Bishayee A, Ahn KS. The Role of Resveratrol in Cancer Therapy. Int J Mol Sci 2017;18:E2589. [PMID: 29194365 DOI: 10.3390/ijms18122589] [Cited by in Crossref: 332] [Cited by in F6Publishing: 355] [Article Influence: 55.3] [Reference Citation Analysis]
|
| 9 |
Kiraz Y, Adan A, Kartal Yandim M, Baran Y. Major apoptotic mechanisms and genes involved in apoptosis. Tumour Biol. 2016;37:8471-8486. [PMID: 27059734 DOI: 10.1007/s13277-016-5035-9] [Cited by in Crossref: 299] [Cited by in F6Publishing: 272] [Article Influence: 42.7] [Reference Citation Analysis]
|
| 10 |
Rodríguez-Hernández A, Navarro-Villarán E, González R, Pereira S, Soriano-De Castro LB, Sarrias-Giménez A, Barrera-Pulido L, Álamo-Martínez JM, Serrablo-Requejo A, Blanco-Fernández G, Nogales-Muñoz A, Gila-Bohórquez A, Pacheco D, Torres-Nieto MA, Serrano-Díaz-Canedo J, Suárez-Artacho G, Bernal-Bellido C, Marín-Gómez LM, Barcena JA, Gómez-Bravo MA, Padilla CA, Padillo FJ, Muntané J. Regulation of cell death receptor S-nitrosylation and apoptotic signaling by Sorafenib in hepatoblastoma cells. Redox Biol 2015;6:174-82. [PMID: 26233703 DOI: 10.1016/j.redox.2015.07.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 11 |
Wu H, Che X, Zheng Q, Wu A, Pan K, Shao A, Wu Q, Zhang J, Hong Y. Caspases: a molecular switch node in the crosstalk between autophagy and apoptosis. Int J Biol Sci 2014;10:1072-83. [PMID: 25285039 DOI: 10.7150/ijbs.9719] [Cited by in Crossref: 168] [Cited by in F6Publishing: 176] [Article Influence: 18.7] [Reference Citation Analysis]
|
| 12 |
Zhang JS, Herreros-Villanueva M, Koenig A, Deng Z, de Narvajas AA, Gomez TS, Meng X, Bujanda L, Ellenrieder V, Li XK, Kaufmann SH, Billadeau DD. Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells. Cell Death Dis 2014;5:e1142. [PMID: 24675460 DOI: 10.1038/cddis.2014.102] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 13 |
Zhang JS, Herreros-Villanueva M, Koenig A, Deng Z, de Narvajas AA, Gomez TS, Meng X, Bujanda L, Ellenrieder V, Li XK. Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells. Cell Death Dis. 2014;5:e1142. [PMID: 24675460 DOI: 10.1038/cddis.2014.341] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 14 |
Zeestraten EC, Benard A, Reimers MS, Schouten PC, Liefers GJ, van de Velde CJ, Kuppen PJ. The prognostic value of the apoptosis pathway in colorectal cancer: a review of the literature on biomarkers identified by immunohistochemistry. Biomark Cancer 2013;5:13-29. [PMID: 24179395 DOI: 10.4137/BIC.S11475] [Cited by in Crossref: 46] [Cited by in F6Publishing: 59] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 15 |
Azijli K, Weyhenmeyer B, Peters GJ, de Jong S, Kruyt FA. Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family. Cell Death Differ 2013;20:858-68. [PMID: 23579241 DOI: 10.1038/cdd.2013.28] [Cited by in Crossref: 126] [Cited by in F6Publishing: 131] [Article Influence: 12.6] [Reference Citation Analysis]
|
| 16 |
Owonikoko TK, Hossain MS, Bhimani C, Chen Z, Kim S, Ramalingam SS, Sun SY, Shin DM, Waller EK, Khuri FR. Soluble FAS ligand as a biomarker of disease recurrence in differentiated thyroid cancer. Cancer 2013;119:1503-11. [PMID: 23340930 DOI: 10.1002/cncr.27937] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 17 |
Dan M, Chantler JK. A novel pancreatropic coxsackievirus vector expressing glucagon-like peptide 1 reduces hyperglycemia in streptozotocin-treated mice. J Virol 2011;85:12759-68. [PMID: 21937637 DOI: 10.1128/JVI.00661-11] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 18 |
Bunek J, Kamarajan P, Kapila YL. Anoikis mediators in oral squamous cell carcinoma. Oral Dis 2011;17:355-61. [PMID: 21114588 DOI: 10.1111/j.1601-0825.2010.01763.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Macfarlane M. Death Receptors at the Molecular Level: Therapeutic Implications. eLS 2009. [DOI: 10.1002/9780470015902.a0021998] [Reference Citation Analysis]
|
| 20 |
Agostinelli E, Seiler N. Non-irradiation-derived reactive oxygen species (ROS) and cancer: therapeutic implications. Amino Acids 2006;31:341-55. [PMID: 16680401 DOI: 10.1007/s00726-005-0271-8] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 21 |
Dumitru CA, Gulbins E. TRAIL activates acid sphingomyelinase via a redox mechanism and releases ceramide to trigger apoptosis. Oncogene 2006;25:5612-25. [PMID: 16636669 DOI: 10.1038/sj.onc.1209568] [Cited by in Crossref: 123] [Cited by in F6Publishing: 126] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 22 |
Seiler N, Raul F. Polyamines and apoptosis. J Cell Mol Med. 2005;9:623-642. [PMID: 16202210 DOI: 10.1111/j.1582-4934.2005.tb00493.x] [Cited by in Crossref: 224] [Cited by in F6Publishing: 227] [Article Influence: 12.4] [Reference Citation Analysis]
|
